Cargando…
Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series
BACKGROUND: Refractory asthma represents an important condition, with considerable morbidity and mortality. Tumor necrosis factor α (TNF-α) is a potential target for treatment of severe asthma. However, controlled studies have shown controversial results and the risk-benefit profile of TNF-blocking...
Autores principales: | Taillé, Camille, Poulet, Claire, Marchand-Adam, Sylvain, Borie, Raphaël, Dombret, Marie-Christine, Crestani, Bruno, Aubier, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601337/ https://www.ncbi.nlm.nih.gov/pubmed/23526476 http://dx.doi.org/10.2174/1874306401307010021 |
Ejemplares similares
-
Focal bronchial dilatations after thermoplasty for severe asthma
por: Thibaut de Ménonville, Charlotte, et al.
Publicado: (2020) -
Perip7lakin is a target for autoimmunity in asthma
por: Taillé, Camille, et al.
Publicado: (2016) -
[(18)F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
por: Justet, Aurélien, et al.
Publicado: (2017) -
The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019) -
Familial pulmonary fibrosis: a world without frontiers
por: Borie, Raphael, et al.
Publicado: (2019)